Infleqtion Posts Record Q2 Revenue but Shares Drop on Wider Losses and Dilution Concerns
Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.
NOTRELOAD AI
Virgin Galactic Shares Fall After Delaying First Commercial Flight to February 2027
SPCE stock drops as Virgin Galactic delays first commercial Delta-class flight to February 2027, despite Q2 earnings beat and strong ticket demand.
PTC Acquires Near-Approval ST-920 Fabry Gene Therapy in Bankruptcy Auction
PTC Therapeutics acquires BLA-stage ST-920, a one-time AAV gene therapy for Fabry disease, with potential U.S. launch in 2027 and strong clinical data.
Cisco’s AI Networking Boom Delivers Record Quarter — Investors Still Sell the News
With elevated expectations already high, Cisco beats on revenue and EPS while raising its full-year outlook on robust AI networking orders.
Cerebras Falls Sharply on GAAP Optics and Soft Sequential Outlook
Cerebras lifts full-year revenue and margin guidance on strong core results and cloud growth, while Q3 outlook signals only limited sequential acceleration.
Mixed News for Neurocrine: Strong TD Data for INGREZZA, Caution on Vykat XR
Neurocrine reports strong KINECT-PRO results for INGREZZA in tardive dyskinesia quality of life, while experts flag safety risks for Vykat XR.